Hover to zoom
GLP-1 & MetabolicSynthetic research compound
Retatrutide / Cagrilintide
$79.99
5/5 mgThis preparation supplies retatrutide — investigated as a GIP, GLP-1, and glucagon receptor agonist — together with cagrilintide, a long-acting amylin analog, in a single lyophilized vial.
It is intended for laboratory research examining several metabolic receptor systems in parallel within one experimental condition.
Research areas
Triple receptor agonismAmylin receptor signalingCombined-pathway researchPreclinical research
Form: Lyophilized (freeze-dried)
- Compound class
- Synthetic research compound
- Research category
- GLP-1 & Metabolic
- SKU
- NVR-RETATRUTIDE-CAGRILINTIDE-5-5MG
- Appearance
- Lyophilized powder
- Storage
- Store lyophilized at −20 °C. Protect from light and moisture.
Research use only
Strength
5/5 mg$79.99$8.00/mg
1
$79.99per 5/5 mg$8.00/mg
For research use only — not for human or animal consumption.
Supplied solely for legitimate laboratory and research purposes. Not for medical or veterinary use, diagnosis, treatment, or prevention of disease.
Research Grade
Batch Documentation
Research Use Only
U.S.-Based Fulfillment
What you should know
More detail on Retatrutide / Cagrilintide.
Analytical values reflect per-lot documentation and appear once a batch is released.
Compound
This blend brings together four receptor activities across two molecules, which makes it a broad probe rather than a selective one. That breadth is deliberate: some preclinical questions concern how multiple metabolic signals behave in combination rather than how any single receptor responds in isolation. Investigators should note that attributing an observed result to a specific receptor is not possible with a combined preparation, and appropriate single-agonist controls are typically required. Both component compounds are relatively recent additions to the literature and remain under active investigation.
Peptide class
Synthetic research compound
Mechanism (research context)
Extended mechanistic characterization for this compound is available in the published literature. Consult peer-reviewed references for detailed pathway analysis.
Why it is studied
Retatrutide / Cagrilintide is studied within its research category (GLP-1 & Metabolic) as a defined-sequence reference compound for laboratory investigation.
Current areas of research
Triple receptor agonismAmylin receptor signalingCombined-pathway researchPreclinical research
Topics reflect published preclinical and in vitro research. Reference only — not a claim of clinical outcomes.
Scientific background
Retatrutide / Cagrilintide is supplied for in vitro laboratory research. Batch-specific analytical documentation is provided when available for the released lot.
Related
View all →Related research materials
Cagrilintide
10 mg
Long-acting amylin analog studied for amylin and calcitonin receptor signaling in laboratory models.
$99.99
DetailsCagrilintide / Semaglutide
5/5 mg
Research blend pairing an amylin analog with a GLP-1 receptor agonist for combined-pathway studies.
$119.99
DetailsHGH Fragment 176-191
5 mg
Unmodified C-terminal growth-hormone fragment used in comparative adipose-tissue research.
$69.99
DetailsRetatrutide / Cagrilintide
5/5 mg · $79.99